
### [Orphanet:169826](http://www.orpha.net/ORDO/Orphanet_169826)
**Label:** Congenital vitamin K-dependent coagulation factors deficiency

**Subclasses:** [Orphanet:98434](http://www.orpha.net/ORDO/Orphanet_98434) (Hereditary combined deficiency of vitamin K-dependent clotting factors), [Orphanet:328](http://www.orpha.net/ORDO/Orphanet_328) (Congenital factor X deficiency), [Orphanet:327](http://www.orpha.net/ORDO/Orphanet_327) (Congenital factor VII deficiency), [Orphanet:325](http://www.orpha.net/ORDO/Orphanet_325) (Congenital factor II deficiency), 

**Corr. equiv. classes:** [OMIM:277450](http://purl.obolibrary.org/obo/OMIM_277450), [OMIM:227500](http://purl.obolibrary.org/obo/OMIM_227500), [Orphanet:328](http://www.orpha.net/ORDO/Orphanet_328), [OMIM:613679](http://purl.obolibrary.org/obo/OMIM_613679), [Orphanet:327](http://www.orpha.net/ORDO/Orphanet_327), [OMIM:227600](http://purl.obolibrary.org/obo/OMIM_227600), [OMIM:607473](http://purl.obolibrary.org/obo/OMIM_607473), [Orphanet:98434](http://www.orpha.net/ORDO/Orphanet_98434), [Orphanet:325](http://www.orpha.net/ORDO/Orphanet_325), 

**Class expressions from DL-Learner:**

- [HP:0000858](http://purl.obolibrary.org/obo/HP_0000858) (Menstrual irregularities) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000140](http://purl.obolibrary.org/obo/HP_0000140) (Abnormality of the menstrual cycle) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0000858](http://purl.obolibrary.org/obo/HP_0000858) (Menstrual irregularities) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0000225](http://purl.obolibrary.org/obo/HP_0000225) (Gingival bleeding) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 66.67%
- [HP:0000225](http://purl.obolibrary.org/obo/HP_0000225) (Gingival bleeding) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000225](http://purl.obolibrary.org/obo/HP_0000225) (Gingival bleeding) and [HP:0001367](http://purl.obolibrary.org/obo/HP_0001367) (Abnormal joint morphology) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000225](http://purl.obolibrary.org/obo/HP_0000225) (Gingival bleeding) and [HP:0000858](http://purl.obolibrary.org/obo/HP_0000858) (Menstrual irregularities) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%


